Pure Global

T3 Rapid Quantitative Test - India CDSCO Medical Device Registration

T3 Rapid Quantitative Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000074_fbfe48e688b5bbb164cdce1c39e00443_6d758f05e7205c87d397848085f4539f. This device is marketed under the brand name Glycated Hemoglobin. The license holder is FINOVA HEALTHCARE PRIVATE LIMITED, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
T3 Rapid Quantitative Test
UID: IMP/IVD/2022/000074_fbfe48e688b5bbb164cdce1c39e00443_6d758f05e7205c87d397848085f4539f

Brand Name

Glycated Hemoglobin

Device Class

Class B

Approving Authority

CDSCO

Product Information

The TT3 (Glycated Hemoglobin) Rapid Quantitative Test along with Aehealth FIA Meter is intended for vitro quantitative determination of Total Triiodothyronine (Glycated Hemoglobin) in human serum or plasma. The test is used as an aid in the functional diagnosis of thyroidea

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing